Practical and Theoretical Radiotherapy Physics Courses
Course overview
This course provides practical and theoretical education for the support of a modern radiotherapy physics service within radiotherapy.
It is aimed primarily at recently qualified radiotherapy physicists, but should also be invaluable to post-graduate students, researchers, clinical oncologists, engineers, radiographers, manufacturers’ representatives and in fact, anyone needing to deepen or update their understanding of this rapidly evolving field.
The faculty is composed of physicists, clinicians and radiographers, many of whom are internationally renowned for their expertise. Workshops and demonstrations make full use of the facilities of the Radiotherapy and Physics Departments of The Royal Marsden NHS Foundation Trust. The course content is reviewed annually to reflect changes in practice and technology.
Course details
10-14 March 2026: the course in November will be held at our Chelsea Site
Course fees
The cost for one week is £800.00. For those wishing to book the complete two weeks, the cost is discounted to £1,350.
External, full-time PhD students with proof of academic registration can book the eight lecture days of both weeks for a total of £700.
For registration details you can email our course secretary.
Contacts
Further details on course content can be obtained from the course organisers:
Tel: +44 (0)20 7808 2506
Fax: +44 (0)20 7808 2522
Tel: +44 (0)20 8661 3475
Fax: +44 (0)20 8643 3812
Latest ICR News
The ICR welcomes NHS decision to grant lifesaving prostate cancer drug to men in England
The Institute of Cancer Research, London, has welcomed the announcement that the lifesaving drug abiraterone has been approved for use on the NHS for men in England with prostate cancer that has a high risk of spreading.
New research uncovers critical DNA repair mechanism during cell division
A major advance in cell biology has revealed how our cells safeguard their genetic material during one of the most vulnerable moments in their life cycle. The study identifies a specific protein complex as a central coordinator of DNA repair during cell division.
Tumour samples from the 1950s could help unlock the mystery of rising bowel cancer cases in the under 50s
Tens of thousands of tumour samples which have been stored in the basement of a London hospital for more than 70 years could be the key to unlocking the mystery of why bowel cancer cases are rising in the under 50s, scientists believe.
Researchers at The Institute of Cancer Research, London, and St Marks Hospital are launching a pioneering study to compare bowel cancer specimens from the 1960s with modern-day cancer samples.
Drug discoverer Paul Workman awarded OBE in New Year’s Honours list
Professor Paul Workman, drug discovery scientist and former Chief Executive of the ICR, has been awarded an OBE in the New Year Honours list 2026 for services to cancer research.